查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866720

紫杉叶素：全球市场份额和排名、总收入和需求预测（2025-2031年）

Taxifolin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 91 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球紫杉叶素市场规模估计为 2,600 万美元，预计到 2031 年将达到 3,818 万美元，在 2025 年至 2031 年的预测期内，复合年增长率为 4.1%。

本报告对近期关税调整和国际战略反制措施对塔克西福林跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

预计到2024年，全球紫杉叶素销售量将达到20,000公斤，平均售价约1,300美元/公斤。紫杉叶素（又称二氢槲皮素）是一种天然黄酮类化合物，存在于多种植物中，包括西伯利亚落叶松、奶蓟和洋葱。它以其强大的抗氧化、抗炎和抗衰老龄化特性而闻名，是膳食补充剂和护肤品中的常用成分。紫杉叶素的结构与广为人知的黄酮类化合物槲皮素相似，但具有更高的水溶性和稳定性，从而增强了其生物利用度和治疗功效。研究表明，它可能有助于心血管健康、改善免疫功能并保护细胞氧化压力。

全球主要的紫杉叶素生产商包括Amethyst、Robios和JW Health Products。前三大公司占约96%的市占率。亚太地区是最大的市场，约占34%的市场份额，其次是欧洲和美洲。以产品类型划分，纯度低于92%的产品是最大的细分市场，约占72%的市场份额。按应用领域划分，医疗保健产业是最大的应用领域，约占40%的市场。

紫杉醇市场的主要成长要素包括：

一、医药领域需求的快速成长与临床应用的扩展

1. 扩大抗癌药物的核心成分与适应症

显着的抗癌效果：紫杉碱是一种天然抗癌活性成分，对治疗乳癌和卵巢癌等固体癌具有显着疗效。预计到2023年，全球市场规模将达到9.2亿美元，其中中国将占28%。标靶药物的研发正在加速，针对肺癌和胃癌等适应症的临床试验数量较2020年增加了3.2倍。预计到2025年，这些药物将推动市占率成长8亿至10亿元。

政策支援与医疗覆盖：国家药品监督管理局发布的《抗癌药物优先审查技术指南》加快了紫杉烷类药物的审查速度，将核准週期缩短至180个工作天。医保覆盖的动态调整使紫杉醇类药物的健保覆盖率从65%提高到82%，使年度治疗费用降至3.2万至4.8万元，显着提高了药物的可及性。 2. 製剂技术创新与研发投入

新型药物传输系统：脂质体传输系统和奈米晶体技术等新型药物传输方法提高了生物利用度 40-60%，并降低了药物毒性和副作用约 30%。

二、保健食品和化妆品市场消费的日益精细化

1. 对天然抗氧化剂的需求正在飙升

健康意识的提高：全球对慢性疾病和氧化压力相关疾病的认识不断提高，推动了消费者对天然抗氧化剂和保健品的需求。

机能性食品和农业应用

2. 化妆品功效显着提高

抗衰老和美白功效：浓度0.5%的紫杉叶素可在8週内将皮肤弹性提高27%，皱纹深度减少33%。它也能非竞争性抑制酪胺酸酶活性，其功效优于熊果苷。

高端品牌应用：Proya等品牌已将其作为核心成分，使相关产品的价格溢价提高了300-500%。医用敷料用于雷射手术后的修復，以减少红斑和色素沉淀。

三、透过技术创新和成本优化促进工业化

1. 萃取技术创新及对环境法规的回应

超临界二氧化碳萃取技术：其应用率将从2020年的18%增加到2025年的43%，并将残留溶剂含量降至0.02 ppm以下。符合西方cGMP标准的企业数量预计将增加300%。

合成生物学与细胞培养：化学合成（半合成与全合成）因其成本低、产率高，已成为主流製备方法。某上市公司的50吨生物反应器生产线，提取效率提高了12倍，单週期生产成本降低了58%。

2. 原料供应与永续

扩大人工栽培基地：天然红豆杉资源有限，因此人工栽培面积以年均24%的速度扩张，预计2023年将达到12.8万亩。云南和四川两省预计将占国内原料供应量的65%。已启动「万亩（约667公顷）红豆杉GAP基地」计划建设，目标是到2027年实现70%的原料自给率。推动环保政策：超临界二氧化碳萃取技术减少了溶剂污染，满足了永续发展的要求，并推动了产业向绿色製造的转型。

由于医药行业需求的爆炸性增长、膳食补充剂和化妆品消费量的增加、技术进步和成本优化，紫杉叶素市场正在经历快速增长。

本报告旨在对全球紫杉叶素市场按地区/国家、类型和应用进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（公斤）和收入（百万美元）为单位，对紫杉叶素市场规模、估算和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定紫杉叶素的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Ametis JSC
  • Jilin Jianwei Natural Biotechnology
  • Kalenika Group
  • ROBIOS
  • Xi'an Sost Biotech Co.,Ltd
  • Focusherb
  • Hoycome
  • Herbchem Biotech

按类型分類的细分市场

  • 低于92%
  • 92%～98%
  • 超过98%

应用领域

  • 食品/饮料
  • 卫生保健
  • 化妆品
  • 农业
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Taxifolin was estimated to be worth US$ 26.00 million in 2024 and is forecast to a readjusted size of US$ 38.18 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Taxifolin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global taxifolin sales will reach 20,000 kg, with an average selling price of approximately US$1,300/kg.Taxifolin, also known as dihydroquercetin, is a natural flavonoid found in plants as diverse as Siberian larch, milk thistle, and onion. It is known for its potent antioxidant, anti-inflammatory, and anti-aging properties, making it a popular ingredient in dietary supplements and skincare products. Taxifolin is structurally similar to the well-known flavonoid quercetin, but boasts greater water solubility and stability, enhancing its bioavailability and therapeutic potential. Research suggests it may support cardiovascular health, improve immune function, and protect cells from oxidative stress.

Global key taxifolin players include Ametis, ROBIOS and JW Health Products etc. The top 3 companies hold a share about 96%. Asia-Pacific is the largest market with a share about 34%, followed by Europe and America. In terms of product, the product whose purity is below 92% is the largest segment with a share about 72%. And in terms of applications, the largest application is healthcare with a share about 40%.

The main drivers of the taxusin market include the following:

I. Explosive demand in the pharmaceutical sector and expansion of clinical applications

1. Expansion of core ingredients and indications for anticancer drugs

Significant anticancer effects: Taxusin, a natural anticancer active ingredient, is highly effective in treating solid tumors such as breast and ovarian cancer. The global market size is expected to reach US$920 million in 2023, with China accounting for 28%. Targeted drug development is accelerating, with the number of clinical trials for indications such as lung and gastric cancer increasing 3.2-fold compared to 2020. It is expected that these drugs will contribute an incremental market share of 800 million to 1 billion yuan in 2025.

Policy support and medical insurance coverage: The National Medical Products Administration's "Technical Guidelines for Priority Review of Anticancer Drugs" has fast-tracked taxusin compound preparations, shortening the approval cycle to 180 working days. Dynamic adjustments to the medical insurance catalog have increased the reimbursement rate for paclitaxel-based drugs from 65% to 82%, reducing annual treatment costs for patients to 32,000 to 48,000 yuan, significantly improving drug accessibility. 2. Formulation Technology Innovation and R&D Investment

New Drug Delivery Systems: New drug delivery methods such as liposome delivery systems and nanocrystal technology have increased bioavailability by 40%-60% and reduced drug toxicity and side effects by approximately 30%.

II. Consumption Upgrade in the Health Products and Cosmetics Market

1. Surge in Demand for Natural Antioxidants

Rising Health Awareness: Global awareness of chronic diseases and oxidative stress-related conditions is increasing, driving consumer demand for natural antioxidants and health supplements.

Functional Foods and Agricultural Applications

2. Efficacy Breakthroughs in Cosmetics

Anti-Aging and Whitening Effects: Taxifolin at a concentration of 0.5% can increase skin elasticity by 27% and reduce wrinkle depth by 33% for eight weeks. It also non-competitively inhibits tyrosinase activity, surpassing arbutin in effectiveness.

High-End Brand Applications: Brands such as Proya use it as a core ingredient, driving price premiums of 300%-500% for related products. Medical dressings are used for post-laser surgery repair, reducing erythema and hyperpigmentation.

III. Technological Advances and Cost Optimization Drive Industrialization

1. Extraction Technology Breakthroughs and Environmental Compliance

Supercritical CO2 Extraction Technology: The penetration rate will increase from 18% in 2020 to 43% in 2025, with residual solvent levels reduced to below 0.02 ppm. The number of companies meeting European and American cGMP standards will increase by 300%.

Synthetic Biology and Cell Culture: Chemical synthesis (semi-synthesis and total synthesis) has become the mainstream preparation method due to its low cost and high yield. A listed company's 50-ton bioreactor production line has increased extraction efficiency by 12-fold and reduced single-cycle production costs by 58%.

2. Raw Material Supply and Sustainable Development

Expansion of Artificial Planting Bases: Wild yew resources are limited, and the area of artificial planting is expanding at an average annual rate of 24%, reaching 128,000 mu in 2023. Yunnan and Sichuan will together contribute 65% of the national raw material supply. Construction of the "10,000 Mu Yew GAP Base" project has commenced, with an expected raw material self-sufficiency rate of 70% by 2027. Driven by environmental policies: Supercritical CO2 extraction technology reduces solvent pollution, aligns with sustainable development requirements, and promotes the industry's transition to green manufacturing.

The taxifolin market is experiencing rapid growth driven by explosive demand in the pharmaceutical sector, rising consumption of health supplements and cosmetics, and technological advancements and cost optimization.

This report aims to provide a comprehensive presentation of the global market for Taxifolin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Taxifolin by region & country, by Type, and by Application.

The Taxifolin market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taxifolin.

Market Segmentation

By Company

  • Ametis JSC
  • Jilin Jianwei Natural Biotechnology
  • Kalenika Group
  • ROBIOS
  • Xi'an Sost Biotech Co.,Ltd
  • Focusherb
  • Hoycome
  • Herbchem Biotech

Segment by Type

  • Below 92%
  • 92%-98%
  • Above 98%

Segment by Application

  • Food and Beverages
  • Healthcare
  • Cosmetics
  • Agriculture
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Taxifolin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Taxifolin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Taxifolin Product Introduction
  • 1.2 Global Taxifolin Market Size Forecast
    • 1.2.1 Global Taxifolin Sales Value (2020-2031)
    • 1.2.2 Global Taxifolin Sales Volume (2020-2031)
    • 1.2.3 Global Taxifolin Sales Price (2020-2031)
  • 1.3 Taxifolin Market Trends & Drivers
    • 1.3.1 Taxifolin Industry Trends
    • 1.3.2 Taxifolin Market Drivers & Opportunity
    • 1.3.3 Taxifolin Market Challenges
    • 1.3.4 Taxifolin Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Taxifolin Players Revenue Ranking (2024)
  • 2.2 Global Taxifolin Revenue by Company (2020-2025)
  • 2.3 Global Taxifolin Players Sales Volume Ranking (2024)
  • 2.4 Global Taxifolin Sales Volume by Company Players (2020-2025)
  • 2.5 Global Taxifolin Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Taxifolin Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Taxifolin Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Taxifolin
  • 2.9 Taxifolin Market Competitive Analysis
    • 2.9.1 Taxifolin Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Taxifolin Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxifolin as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Below 92%
    • 3.1.2 92%-98%
    • 3.1.3 Above 98%
  • 3.2 Global Taxifolin Sales Value by Type
    • 3.2.1 Global Taxifolin Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Taxifolin Sales Value, by Type (2020-2031)
    • 3.2.3 Global Taxifolin Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Taxifolin Sales Volume by Type
    • 3.3.1 Global Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Taxifolin Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Taxifolin Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Taxifolin Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Food and Beverages
    • 4.1.2 Healthcare
    • 4.1.3 Cosmetics
    • 4.1.4 Agriculture
    • 4.1.5 Others
  • 4.2 Global Taxifolin Sales Value by Application
    • 4.2.1 Global Taxifolin Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Taxifolin Sales Value, by Application (2020-2031)
    • 4.2.3 Global Taxifolin Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Taxifolin Sales Volume by Application
    • 4.3.1 Global Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Taxifolin Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Taxifolin Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Taxifolin Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Taxifolin Sales Value by Region
    • 5.1.1 Global Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Taxifolin Sales Value by Region (2020-2025)
    • 5.1.3 Global Taxifolin Sales Value by Region (2026-2031)
    • 5.1.4 Global Taxifolin Sales Value by Region (%), (2020-2031)
  • 5.2 Global Taxifolin Sales Volume by Region
    • 5.2.1 Global Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Taxifolin Sales Volume by Region (2020-2025)
    • 5.2.3 Global Taxifolin Sales Volume by Region (2026-2031)
    • 5.2.4 Global Taxifolin Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Taxifolin Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Taxifolin Sales Value, 2020-2031
    • 5.4.2 North America Taxifolin Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Taxifolin Sales Value, 2020-2031
    • 5.5.2 Europe Taxifolin Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Taxifolin Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Taxifolin Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Taxifolin Sales Value, 2020-2031
    • 5.7.2 South America Taxifolin Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Taxifolin Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Taxifolin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Taxifolin Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Taxifolin Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Taxifolin Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Taxifolin Sales Value, 2020-2031
    • 6.3.2 United States Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Taxifolin Sales Value, 2020-2031
    • 6.4.2 Europe Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Taxifolin Sales Value, 2020-2031
    • 6.5.2 China Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Taxifolin Sales Value, 2020-2031
    • 6.6.2 Japan Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Taxifolin Sales Value, 2020-2031
    • 6.7.2 South Korea Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Taxifolin Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Taxifolin Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Taxifolin Sales Value, 2020-2031
    • 6.9.2 India Taxifolin Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Taxifolin Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Ametis JSC
    • 7.1.1 Ametis JSC Company Information
    • 7.1.2 Ametis JSC Introduction and Business Overview
    • 7.1.3 Ametis JSC Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Ametis JSC Taxifolin Product Offerings
    • 7.1.5 Ametis JSC Recent Development
  • 7.2 Jilin Jianwei Natural Biotechnology
    • 7.2.1 Jilin Jianwei Natural Biotechnology Company Information
    • 7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview
    • 7.2.3 Jilin Jianwei Natural Biotechnology Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Jilin Jianwei Natural Biotechnology Taxifolin Product Offerings
    • 7.2.5 Jilin Jianwei Natural Biotechnology Recent Development
  • 7.3 Kalenika Group
    • 7.3.1 Kalenika Group Company Information
    • 7.3.2 Kalenika Group Introduction and Business Overview
    • 7.3.3 Kalenika Group Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Kalenika Group Taxifolin Product Offerings
    • 7.3.5 Kalenika Group Recent Development
  • 7.4 ROBIOS
    • 7.4.1 ROBIOS Company Information
    • 7.4.2 ROBIOS Introduction and Business Overview
    • 7.4.3 ROBIOS Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 ROBIOS Taxifolin Product Offerings
    • 7.4.5 ROBIOS Recent Development
  • 7.5 Xi'an Sost Biotech Co.,Ltd
    • 7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information
    • 7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
    • 7.5.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Offerings
    • 7.5.5 Xi'an Sost Biotech Co.,Ltd Recent Development
  • 7.6 Focusherb
    • 7.6.1 Focusherb Company Information
    • 7.6.2 Focusherb Introduction and Business Overview
    • 7.6.3 Focusherb Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Focusherb Taxifolin Product Offerings
    • 7.6.5 Focusherb Recent Development
  • 7.7 Hoycome
    • 7.7.1 Hoycome Company Information
    • 7.7.2 Hoycome Introduction and Business Overview
    • 7.7.3 Hoycome Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Hoycome Taxifolin Product Offerings
    • 7.7.5 Hoycome Recent Development
  • 7.8 Herbchem Biotech
    • 7.8.1 Herbchem Biotech Company Information
    • 7.8.2 Herbchem Biotech Introduction and Business Overview
    • 7.8.3 Herbchem Biotech Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Herbchem Biotech Taxifolin Product Offerings
    • 7.8.5 Herbchem Biotech Recent Development

8 Industry Chain Analysis

  • 8.1 Taxifolin Industrial Chain
  • 8.2 Taxifolin Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Taxifolin Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Taxifolin Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Taxifolin Market Trends
  • Table 2. Taxifolin Market Drivers & Opportunity
  • Table 3. Taxifolin Market Challenges
  • Table 4. Taxifolin Market Restraints
  • Table 5. Global Taxifolin Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Taxifolin Revenue Market Share by Company (2020-2025)
  • Table 7. Global Taxifolin Sales Volume by Company (2020-2025) & (KG)
  • Table 8. Global Taxifolin Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Taxifolin Price by Company (2020-2025) & (US$/Ton)
  • Table 10. Key Manufacturers Taxifolin Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Taxifolin Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Taxifolin
  • Table 13. Global Taxifolin Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxifolin as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Taxifolin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Taxifolin Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Taxifolin Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Taxifolin Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Taxifolin Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Taxifolin Sales Volume by Type: 2020 VS 2024 VS 2031 (KG)
  • Table 22. Global Taxifolin Sales Volume by Type (2020-2025) & (KG)
  • Table 23. Global Taxifolin Sales Volume by Type (2026-2031) & (KG)
  • Table 24. Global Taxifolin Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Taxifolin Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Taxifolin Price by Type (2020-2025) & (US$/Ton)
  • Table 27. Global Taxifolin Price by Type (2026-2031) & (US$/Ton)
  • Table 28. Global Taxifolin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Taxifolin Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Taxifolin Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Taxifolin Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Taxifolin Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Taxifolin Sales Volume by Application: 2020 VS 2024 VS 2031 (KG)
  • Table 34. Global Taxifolin Sales Volume by Application (2020-2025) & (KG)
  • Table 35. Global Taxifolin Sales Volume by Application (2026-2031) & (KG)
  • Table 36. Global Taxifolin Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Taxifolin Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Taxifolin Price by Application (2020-2025) & (US$/Ton)
  • Table 39. Global Taxifolin Price by Application (2026-2031) & (US$/Ton)
  • Table 40. Global Taxifolin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Taxifolin Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Taxifolin Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Taxifolin Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Taxifolin Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Taxifolin Sales Volume by Region (KG): 2020 VS 2024 VS 2031
  • Table 46. Global Taxifolin Sales Volume by Region (2020-2025) & (KG)
  • Table 47. Global Taxifolin Sales Volume by Region (2026-2031) & (KG)
  • Table 48. Global Taxifolin Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Taxifolin Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Taxifolin Average Price by Region (2020-2025) & (US$/Ton)
  • Table 51. Global Taxifolin Average Price by Region (2026-2031) & (US$/Ton)
  • Table 52. Key Countries/Regions Taxifolin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Taxifolin Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Taxifolin Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Taxifolin Sales Volume, (2020-2025) & (KG)
  • Table 56. Key Countries/Regions Taxifolin Sales Volume, (2026-2031) & (KG)
  • Table 57. Ametis JSC Company Information
  • Table 58. Ametis JSC Introduction and Business Overview
  • Table 59. Ametis JSC Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 60. Ametis JSC Taxifolin Product Offerings
  • Table 61. Ametis JSC Recent Development
  • Table 62. Jilin Jianwei Natural Biotechnology Company Information
  • Table 63. Jilin Jianwei Natural Biotechnology Introduction and Business Overview
  • Table 64. Jilin Jianwei Natural Biotechnology Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 65. Jilin Jianwei Natural Biotechnology Taxifolin Product Offerings
  • Table 66. Jilin Jianwei Natural Biotechnology Recent Development
  • Table 67. Kalenika Group Company Information
  • Table 68. Kalenika Group Introduction and Business Overview
  • Table 69. Kalenika Group Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 70. Kalenika Group Taxifolin Product Offerings
  • Table 71. Kalenika Group Recent Development
  • Table 72. ROBIOS Company Information
  • Table 73. ROBIOS Introduction and Business Overview
  • Table 74. ROBIOS Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 75. ROBIOS Taxifolin Product Offerings
  • Table 76. ROBIOS Recent Development
  • Table 77. Xi'an Sost Biotech Co.,Ltd Company Information
  • Table 78. Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
  • Table 79. Xi'an Sost Biotech Co.,Ltd Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 80. Xi'an Sost Biotech Co.,Ltd Taxifolin Product Offerings
  • Table 81. Xi'an Sost Biotech Co.,Ltd Recent Development
  • Table 82. Focusherb Company Information
  • Table 83. Focusherb Introduction and Business Overview
  • Table 84. Focusherb Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 85. Focusherb Taxifolin Product Offerings
  • Table 86. Focusherb Recent Development
  • Table 87. Hoycome Company Information
  • Table 88. Hoycome Introduction and Business Overview
  • Table 89. Hoycome Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 90. Hoycome Taxifolin Product Offerings
  • Table 91. Hoycome Recent Development
  • Table 92. Herbchem Biotech Company Information
  • Table 93. Herbchem Biotech Introduction and Business Overview
  • Table 94. Herbchem Biotech Taxifolin Sales (KG), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
  • Table 95. Herbchem Biotech Taxifolin Product Offerings
  • Table 96. Herbchem Biotech Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Taxifolin Downstream Customers
  • Table 100. Taxifolin Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Taxifolin Product Picture
  • Figure 2. Global Taxifolin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Taxifolin Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Taxifolin Sales Volume (2020-2031) & (KG)
  • Figure 5. Global Taxifolin Sales Price (2020-2031) & (US$/Ton)
  • Figure 6. Taxifolin Report Years Considered
  • Figure 7. Global Taxifolin Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Taxifolin Players Sales Volume Ranking (2024) & (KG)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Taxifolin Revenue in 2024
  • Figure 10. Taxifolin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Below 92% Picture
  • Figure 12. 92%-98% Picture
  • Figure 13. Above 98% Picture
  • Figure 14. Global Taxifolin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Taxifolin Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031) & (KG)
  • Figure 17. Global Taxifolin Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Taxifolin Price by Type (2020-2031) & (US$/Ton)
  • Figure 19. Product Picture of Food and Beverages
  • Figure 20. Product Picture of Healthcare
  • Figure 21. Product Picture of Cosmetics
  • Figure 22. Product Picture of Agriculture
  • Figure 23. Product Picture of Others
  • Figure 24. Global Taxifolin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 25. Global Taxifolin Sales Value Market Share by Application, 2024 & 2031
  • Figure 26. Global Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031) & (KG)
  • Figure 27. Global Taxifolin Sales Volume Market Share by Application, 2024 & 2031
  • Figure 28. Global Taxifolin Price by Application (2020-2031) & (US$/Ton)
  • Figure 29. North America Taxifolin Sales Value (2020-2031) & (US$ Million)
  • Figure 30. North America Taxifolin Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Europe Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Taxifolin Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Asia Pacific Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Asia Pacific Taxifolin Sales Value by Region (%), 2024 VS 2031
  • Figure 35. South America Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. South America Taxifolin Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Middle East & Africa Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Middle East & Africa Taxifolin Sales Value by Country (%), 2024 VS 2031
  • Figure 39. Key Countries/Regions Taxifolin Sales Value (%), (2020-2031)
  • Figure 40. Key Countries/Regions Taxifolin Sales Volume (%), (2020-2031)
  • Figure 41. United States Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. United States Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 43. United States Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Europe Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Europe Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Europe Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 47. China Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. China Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 49. China Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Japan Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Japan Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Japan Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 53. South Korea Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. South Korea Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 55. South Korea Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 56. Southeast Asia Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. Southeast Asia Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 58. Southeast Asia Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 59. India Taxifolin Sales Value, (2020-2031) & (US$ Million)
  • Figure 60. India Taxifolin Sales Value by Type (%), 2024 VS 2031
  • Figure 61. India Taxifolin Sales Value by Application (%), 2024 VS 2031
  • Figure 62. Taxifolin Industrial Chain
  • Figure 63. Taxifolin Manufacturing Cost Structure
  • Figure 64. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed